Loading
Major Depressive Disorder (MDD) · Interventional Study
ClinicalTrials.gov · August 14, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a registered clinical trial protocol for home-based transcranial direct current stimulation (tDCS) in major depressive disorder, currently recruiting. No results are reported in this registry record; the study is designed to compare active tDCS to sham over 10 weeks using blinded, randomized allocation and the Montgomery-Åsberg Depression Rating Scale as the primary measure.
Interventional, Randomized, Parallel, Quadruple masking, Treatment purpose. Major Depressive Disorder (MDD); age from 22 Years; to 70 Years. Intervention: Active treatment. Compared with: Sham treatment — Sham Comparator. n = 200. 1 site: United States.
This is a registered clinical trial protocol for home-based transcranial direct current stimulation (tDCS) in major depressive disorder, currently recruiting. No results are reported in this registry record; the study is designed to compare active tDCS to sham over 10 weeks using blinded, randomized allocation and the Montgomery-Åsberg Depression Rating Scale as the primary measure.
This is a registry record only; no efficacy or safety results are reported.
The source did not state who this applies to in practice.
This is a registry record of an ongoing recruiting trial with no results posted; it describes the planned design and endpoints only, not efficacy or safety data.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06976697). This is a study registration, not published results. Lead sponsor: Sooma Medical Inc. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 200 participants (ESTIMATED). Conditions: Major Depressive Disorder (MDD). Interventions: DEVICE: Transcranial direct current stimulation; DEVICE: Sham transcranial direct current stimulation. Primary outcome measures: MADRS: change from baseline , 10 weeks from treatment initiation.. Brief summary: The REACH-tDCS study will evaluate the safety and efficacy of a noninvasive, at-home self-administered Sooma tDCS brain stimulation treatment for Major Depressive Disorder. The study uses randomized, blinded, placebo controlled design. The participants are assessed with video interviews and self-reports during the study, which lasts for 10 weeks followed by an optional continuation period.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.